Is Rubinstein-Taybi Syndrome hereditary?

Rubinstein-Taybi Syndrome is a genetic condition, but it is rarely hereditary. In the vast majority of cases, Rubinstein-Taybi Syndrome is caused by a de novo (spontaneous) mutation that occurs for the first time in the affected individual, meaning it is not passed down from parents.

Is Rubinstein-Taybi Syndrome hereditary?

While Rubinstein-Taybi Syndrome is fundamentally a genetic condition—meaning it is caused by changes (mutations) in specific genes—it is generally not considered an inherited or hereditary condition in the traditional sense. Most individuals with Rubinstein-Taybi Syndrome have no family history of the disorder. The condition is caused by mutations in the CREBBP or EP300 genes, which are essential for normal growth and development. Because these mutations typically occur spontaneously during the formation of reproductive cells or early embryonic development, the parents of an affected child usually have a very low risk of having another child with the syndrome.

What is the role of de novo mutations in this condition?

The overwhelming majority of Rubinstein-Taybi Syndrome cases result from de novo mutations. This means the genetic alteration happened "out of the blue" in the egg or sperm cell that formed the embryo, or shortly after fertilization. Because these mutations are not inherited from parents, the recurrence risk for siblings of an affected individual is generally estimated to be less than 1%. However, in extremely rare instances, a parent may carry a mutation in a mosaic state (where only some of their cells carry the change), which would slightly increase the risk of recurrence.

How is genetic testing used for diagnosis?

Genetic testing is the gold standard for confirming a diagnosis of Rubinstein-Taybi Syndrome. When a clinician suspects the syndrome based on physical features—such as broad thumbs and great toes, short stature, and characteristic facial features—they will order molecular genetic testing. Common testing methods include:

• Sequence analysis: Targeted testing of the CREBBP or EP300 genes to identify specific mutations.


• Deletion/duplication analysis: Testing to determine if a large segment of the gene is missing or duplicated.


• Chromosomal Microarray (CMA): Often the first-tier test to identify larger deletions involving these genes.

Why is genetic counseling recommended for families?

Genetic counseling is a vital resource for any family navigating a diagnosis of Rubinstein-Taybi Syndrome. A genetic counselor helps parents understand the nature of the specific mutation identified and can interpret the results of clinical testing. For those planning future pregnancies, counselors can provide accurate information regarding recurrence risks and discuss reproductive options, such as prenatal diagnosis or preimplantation genetic testing (PGT) if a familial mutation has been identified. Within the DiseaseMaps.org community, our 232 members often emphasize that speaking with a specialist early on helps alleviate the uncertainty that often accompanies a new diagnosis.

Next steps

• Consult a board-certified clinical geneticist to discuss molecular testing options for your family.


• Request a referral for genetic counseling to receive personalized information regarding inheritance and family planning.


• Connect with the DiseaseMaps.org community to share experiences and find support from others living with Rubinstein-Taybi Syndrome.


• Review your child's specific genetic report with your pediatrician to ensure appropriate long-term clinical monitoring.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with a qualified healthcare professional regarding any medical diagnosis or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Rubinstein-Taybi Syndrome overview.


• Orphanet: Clinical practice guidelines and prevalence data for Rubinstein-Taybi Syndrome.


• OMIM (Online Mendelian Inheritance in Man): Detailed genetic entries for CREBBP and EP300 mutations.


• Rubinstein-Taybi Syndrome Support Foundation: Resources for families and clinical research updates.